Nucleate Podcast

Follow us on https://signal.nucleate.xyz/Peter Barrett discussed his career journey, from starting in a technical role at Perkin Elmer to co-founding Celera Genomics and being part of the team that first sequenced the human genome. He then transitioned to venture capital, joining Atlas Venture, where he has focused on building and investing in innovative therapeutic and drug discov

Follow the Nucleate Podcast on our website: https://signal.nucleate.xyz/Jake Becraft, the co-founder and CEO of Strand Therapeutics, discusses his journey from pursuing a PhD in chemical engineering and synthetic biology at MIT to starting a biotech company focused on developing programmable mRNA therapeutics.At MIT, he worked on developing nanoparticles for DNA delivery and became

We are very excited to have Dr Marina Gerner joining us on the Nucleate Pocast to discuss her book called The Vagina Business. The Vagina Business has already been getting attention with grants from the Alfred P. Sloan Foundation and The Society of Authors. Kirkus Reviews has praised the book as "energetic, thoroughly engaging reading" and emphasized its potential to improve women

Michael Langer has had a diverse and fascinating career, with experience spanning startups, venture capital, biotech, filmmaking, and philanthropy. He was inspired from a young age by his father's work in the Langer Lab and early exposure to the startup world. Langer's background includes formative experiences like an impactful internship at Living Proof and taking time off from co

In this episode, Anastasia Janas interviews Leo Grady, founder and CEO of Jona. With over 20 years in AI and healthcare, Leo has made a profound impact on the field, including leading the development of the first FDA-approved AI system in pathology at Paige.AI. Together, they dive into the journey that led him to create Jona, a company focused on using AI to analyze the gut microbi

In this episode, Sam Kessel and Anastasia Janas interview Luke Timmerman, an award-winning biotech journalist and founder of the Timmerman Report, as well as host of The Long Run Podcast. They explore Luke's non-traditional background, his curiosity, and his openness to learning, which shaped his journey to becoming a prominent figure in the biotech space. Luke shares insights into

In this episode, Sam Kessel speaks with Irene Blat, Senior Director for Search and Evaluation at Servier. Dr Blat discusses her lifelong fascination with science and inspiration to take her Oncology studies to industry to develop new therapies for patients. She discussed the intersection of science and business in Search and Evaluation identifying promising technologies. She talks

In this episode, Sam Kessel and Vianca Williams speak with Fiona Mack, the head of Bayer's Co.Lab in Cambridge. Dr Mack discusses her career path from Cornell and the University of Pennsylvania to Bayer, highlighting her transition from academia to industry. She emphasizes the importance of mentorship and risk-taking in her journey. Dr Mack describes Bayer Co.Lab's mission to suppo

In this episode of the Nucleate Podcast, we are joined by Ananya Zutshi and Ricky Barrett, founders of Guardian Bio, a Boston-based biotech company (and Nucleate Alumni). Their platform focuses on engineering dendritic cells to target solid tumors. We delve into the ups and downs of their entrepreneurial journey, the unique dynamic between co-founders, and their advice for communic

In this episode of the Nucleate Podcast, we are joined by Ananya Zutshi and Ricky Barrett, founders of Guardian Bio, a Boston-based biotech company (and Nucleate Alumni). Their platform focuses on engineering dendritic cells to target solid tumors. We delve into the ups and downs of their entrepreneurial journey, the unique dynamic between co-founders, and their advice for communic